Clover Health Investments, Corp Clov Stock Price, News, Quote & History
Clover Health price target lowered to $4 from $7 at Canaccord Canaccord analyst Richard Close lowered the firm’s price target on Clover Health to $4 from $7 and keeps… WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services. Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services. The financial leaders of tomorrow are shaping the financial services and trends.
As is typical of a bear market, the Nasdaq has led the other major indices lower over the past year. The tech-heavy index is down 28% over the past 12 months compared with a 17% decline in the S&P 500.
Clover Health Investments Clov
A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations.
- Real-time analyst ratings, insider transactions, earnings data, and more.
- The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank.
- Current records show that the company has 477.69M in outstanding shares.
- A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares.
View analysts price targets for CLOV or view top-rated stocks among Wall Street analysts. 6 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Clover Health Investments in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “hold” CLOV shares.
Clover Health Announces Inducement Grant Under Nasdaq Listing Rule 5635c
The company issued revenue guidance of $3.20 billion-$3.40 billion, compared to the consensus revenue estimate of $3.31 billion. Clover Health Investments Corp., which has a market valuation of $497.10 million, is expected to release its quarterly earnings report Feb 21, 2023 – Feb 27, 2023. Analysts tracking CLOV have forecast the quarterly EPS to shrink by -0.24 per share this quarter, while the same analysts predict the annual EPS to hit -$0.88 for the year 2022 and up to -$0.7 for 2023. In this case, analysts estimate an annual EPS growth of 29.00% for the year and 20.50% for the next year. Clover Health Investments released its earnings results on Nov 07, 2022. The company reported -$0.158 earnings per share for the quarter, beating the consensus estimate of -$0.224 by $0.066. Money Flow Uptick/Downtick RatioMoney flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an “uptick” in price and the value of trades made on a “downtick” in price.
But this is just one of the opportunities we have researched in our free report. After all, you don’t typically have a share price below $5 without some https://nationalparksofturkey.org/ problems, be it a failing business plan, poor execution by management,… The technique has proven to be very useful for finding positive surprises.
